Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors. (2020)

First Author: Wanigasooriya K
Attributed to:  Integrating innovative technologies for genotyping and phenotyping in stratified medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers12051278

PubMed Identifier: 32443649

Publication URI: http://europepmc.org/abstract/MED/32443649

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancers

Issue: 5

ISSN: 2072-6694